Balchem (BCPC)
Balchem on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as chemicals & allied products.
493K
Short interest
settlement 2026-09-30
2.1
Days to cover
-1.2 days vs prior
59.6%
Short share of volume
2026-10-23
29
Fails to deliver
settlement 2026-09-28
Fri 19 Feb
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in BCPC is 493,011 shares, down 61,829 shares over the last month. Over the last 48 readings it ranged from 279,089 shares (13 February 2026) to 620,041 shares (15 September 2026). At the reported average volume of 237K shares a day that is 2.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/bcpc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 493,011 | -20.5% | 236,969 | 2.08 |
| 2026-09-15 | 620,041 | +11.8% | 187,775 | 3.30 |
| 2026-08-31 | 554,840 | -8.3% | 159,244 | 3.48 |
| 2026-08-14 | 605,061 | +9.5% | 177,863 | 3.40 |
| 2026-07-31 | 552,349 | -8.6% | 198,622 | 2.78 |
| 2026-07-15 | 604,522 | +16.9% | 239,056 | 2.53 |
| 2026-06-30 | 516,902 | +23.2% | 330,786 | 1.56 |
| 2026-06-15 | 419,454 | +0.9% | 220,096 | 1.91 |
| 2026-05-29 | 415,630 | +11.1% | 159,223 | 2.61 |
| 2026-05-15 | 374,120 | +8.6% | 175,596 | 2.13 |
| 2026-04-30 | 344,621 | +0.5% | 255,797 | 1.35 |
| 2026-04-15 | 342,846 | -9.9% | 167,029 | 2.05 |
| 2026-03-31 | 380,559 | -3.9% | 236,546 | 1.61 |
| 2026-03-13 | 395,898 | +17.3% | 164,514 | 2.41 |
| 2026-02-27 | 337,598 | +21.0% | 170,402 | 1.98 |
| 2026-02-13 | 279,089 | -5.1% | 167,773 | 1.66 |
| 2026-01-30 | 294,197 | -15.4% | 163,512 | 1.80 |
| 2026-01-15 | 347,873 | +19.2% | 145,144 | 2.40 |
| 2025-12-31 | 291,827 | -32.3% | 196,577 | 1.48 |
| 2025-12-15 | 431,077 | -9.3% | 227,297 | 1.90 |
| 2025-11-28 | 475,038 | +3.5% | 164,950 | 2.88 |
| 2025-11-14 | 459,067 | +0.7% | 148,811 | 3.08 |
| 2025-10-31 | 455,881 | +4.3% | 203,730 | 2.24 |
| 2025-10-15 | 436,879 | +0.4% | 152,052 | 2.87 |
| 2025-09-30 | 435,280 | +2.3% | 183,048 | 2.38 |
| 2025-09-15 | 425,613 | -9.2% | 128,882 | 3.30 |
| 2025-08-29 | 468,480 | -8.9% | 147,263 | 3.18 |
| 2025-08-15 | 514,092 | +5.3% | 171,261 | 3.00 |
| 2025-07-31 | 488,378 | +1.9% | 214,850 | 2.27 |
| 2025-07-15 | 479,238 | -4.8% | 130,028 | 3.69 |
| 2025-06-30 | 503,616 | +8.0% | 191,978 | 2.62 |
| 2025-06-13 | 466,353 | -9.9% | 134,734 | 3.46 |
| 2025-05-30 | 517,885 | -4.3% | 131,998 | 3.92 |
| 2025-05-15 | 540,968 | -7.5% | 152,506 | 3.55 |
| 2025-04-30 | 584,663 | +12.6% | 212,021 | 2.76 |
| 2025-04-15 | 519,220 | +10.9% | 221,259 | 2.35 |
| 2025-03-31 | 468,053 | +0.7% | 226,098 | 2.07 |
| 2025-03-14 | 464,607 | +11.5% | 161,862 | 2.87 |
| 2025-02-28 | 416,523 | -6.6% | 165,251 | 2.52 |
| 2025-02-14 | 446,014 | +7.0% | 110,663 | 4.03 |
| 2025-01-31 | 416,739 | -10.6% | 121,510 | 3.43 |
| 2025-01-15 | 465,882 | -2.7% | 128,806 | 3.62 |
| 2024-12-31 | 478,761 | -2.8% | 159,279 | 3.01 |
| 2024-12-13 | 492,351 | +12.8% | 106,323 | 4.63 |
| 2024-11-29 | 436,616 | -10.9% | 98,478 | 4.43 |
| 2024-11-15 | 490,274 | +10.9% | 173,103 | 2.83 |
| 2024-10-31 | 442,206 | -3.8% | 107,840 | 4.10 |
| 2024-10-15 | 459,789 | +4.6% | 86,540 | 5.31 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of BCPC volume is 59.6%, up 15.8 points over the last five sessions. Over the last 30 readings it ranged from 24.4% (25 September 2026) to 67.4% (18 September 2026). The latest reading is 11.5 points above the 30-session average of 48.1%, on 124K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 74K | 124K | 59.6% | 182 |
| 2026-10-22 | 31K | 59K | 52.9% | 39 |
| 2026-10-21 | 16K | 28K | 56.8% | 0 |
| 2026-10-20 | 16K | 39K | 41.7% | 7 |
| 2026-10-19 | 22K | 39K | 56.0% | 0 |
| 2026-10-16 | 27K | 62K | 43.7% | 0 |
| 2026-10-15 | 34K | 70K | 47.9% | 0 |
| 2026-10-14 | 36K | 69K | 51.9% | 0 |
| 2026-10-13 | 23K | 44K | 51.5% | 0 |
| 2026-10-12 | 24K | 45K | 53.3% | 0 |
| 2026-10-09 | 21K | 50K | 43.1% | 0 |
| 2026-10-08 | 31K | 53K | 58.4% | 0 |
| 2026-10-07 | 28K | 52K | 52.9% | 0 |
| 2026-10-06 | 15K | 32K | 47.4% | 0 |
| 2026-10-05 | 22K | 49K | 46.1% | 0 |
| 2026-10-02 | 40K | 69K | 57.4% | 276 |
| 2026-10-01 | 27K | 65K | 40.9% | 34 |
| 2026-09-30 | 25K | 55K | 45.1% | 20 |
| 2026-09-29 | 18K | 45K | 41.0% | 0 |
| 2026-09-28 | 12K | 38K | 31.2% | 10 |
| 2026-09-25 | 12K | 51K | 24.4% | 0 |
| 2026-09-24 | 25K | 61K | 41.1% | 0 |
| 2026-09-23 | 15K | 47K | 31.9% | 0 |
| 2026-09-22 | 28K | 78K | 36.5% | 0 |
| 2026-09-21 | 25K | 52K | 47.2% | 0 |
| 2026-09-18 | 29K | 44K | 67.4% | 0 |
| 2026-09-17 | 36K | 79K | 45.9% | 81 |
| 2026-09-16 | 47K | 85K | 55.5% | 0 |
| 2026-09-15 | 22K | 44K | 50.4% | 0 |
| 2026-09-14 | 67K | 107K | 62.9% | 147 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in BCPC is 29 shares, up 15 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (15 June 2026) to 7,996 shares (12 February 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 29 | $167.89 | $5K |
| 2026-09-22 | 14 | $167.34 | $2K |
| 2026-09-02 | 95 | $173.31 | $16K |
| 2026-08-20 | 40 | $180.19 | $7K |
| 2026-08-19 | 15 | $177.00 | $3K |
| 2026-08-18 | 15 | $178.38 | $3K |
| 2026-08-17 | 15 | $178.51 | $3K |
| 2026-08-03 | 245 | $167.56 | $41K |
| 2026-07-30 | 23 | $163.71 | $4K |
| 2026-07-28 | 359 | $164.79 | $59K |
| 2026-07-23 | 138 | $162.10 | $22K |
| 2026-07-22 | 90 | $161.12 | $15K |
| 2026-07-20 | 87 | $163.35 | $14K |
| 2026-06-22 | 476 | $165.92 | $79K |
| 2026-06-15 | 1 | $165.04 | $165 |
| 2026-06-04 | 631 | $156.62 | $99K |
| 2026-05-27 | 2,139 | $161.50 | $345K |
| 2026-05-19 | 1,024 | $159.47 | $163K |
| 2026-04-22 | 270 | $175.68 | $47K |
| 2026-04-02 | 18 | $171.88 | $3K |
| 2026-03-11 | 195 | $171.78 | $33K |
| 2026-03-10 | 9 | $172.65 | $2K |
| 2026-02-27 | 183 | $180.29 | $33K |
| 2026-02-20 | 7 | $175.00 | $1K |
| 2026-02-13 | 17 | $177.49 | $3K |
| 2026-02-12 | 7,996 | $178.68 | $1.4M |
| 2026-01-16 | 22 | $166.01 | $4K |
| 2026-01-08 | 366 | $154.69 | $57K |
| 2025-12-16 | 13 | $158.71 | $2K |
| 2025-12-05 | 54 | $153.35 | $8K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for BCPC in the last 90 days. The most recent filings are listed below. Latest filing: van Gunsteren Job Leonard (SVP and GM, Specialty Products) on 2026-02-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Tax withholding | 58 | $177.49 | $10K | 10K |
| 2026-02-12 | Reid Martin Luther | SVP Chief Supply Chain Officer | Tax withholding | 116 | $177.49 | $21K | 9K |
| 2026-02-12 | Harris Theodore L | Chairman, President & CEO | Tax withholding | 844 | $177.49 | $150K | 91K |
| 2026-02-12 | Backus William A. | VP & Chief Accounting Officer | Tax withholding | 70 | $177.49 | $12K | 7K |
| 2026-02-12 | Boned Frederic | SVP/GM, Human Nutri. & Health | Tax withholding | 203 | $177.49 | $36K | 9K |
| 2026-02-12 | Tignor Michael Brent | SVP & Chief HR Officer | Tax withholding | 165 | $177.49 | $29K | 11K |
| 2026-02-12 | Miyata Hatsuki | EVP, CLO, & Secretary | Tax withholding | 181 | $177.49 | $32K | 9K |
| 2026-02-12 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Tax withholding | 302 | $177.49 | $54K | 28K |
| 2026-02-11 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Tax withholding | 756 | $178.68 | $135K | 10K |
| 2026-02-11 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Grant | 1K | $0.00 | $0 | 11K |
| 2026-02-11 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Grant | 430 | $0.00 | $0 | 10K |
| 2026-02-11 | Reid Martin Luther | SVP Chief Supply Chain Officer | Tax withholding | 1K | $178.68 | $194K | 9K |
| 2026-02-11 | Reid Martin Luther | SVP Chief Supply Chain Officer | Grant | 2K | $0.00 | $0 | 10K |
| 2026-02-11 | Reid Martin Luther | SVP Chief Supply Chain Officer | Grant | 940 | $0.00 | $0 | 8K |
| 2026-02-11 | Harris Theodore L | Chairman, President & CEO | Tax withholding | 9K | $178.68 | $1.7M | 92K |
| 2026-02-11 | Harris Theodore L | Chairman, President & CEO | Grant | 18K | $0.00 | $0 | 102K |
| 2026-02-11 | Harris Theodore L | Chairman, President & CEO | Grant | 7K | $0.00 | $0 | 83K |
| 2026-02-11 | Graham George | SVP and Chief R&D Officer | Grant | 700 | $0.00 | $0 | 3K |
| 2026-02-11 | Backus William A. | VP & Chief Accounting Officer | Tax withholding | 865 | $178.68 | $155K | 7K |
| 2026-02-11 | Backus William A. | VP & Chief Accounting Officer | Grant | 2K | $0.00 | $0 | 8K |
| 2026-02-11 | Backus William A. | VP & Chief Accounting Officer | Grant | 490 | $0.00 | $0 | 6K |
| 2026-02-11 | Boned Frederic | SVP/GM, Human Nutri. & Health | Tax withholding | 1K | $178.68 | $206K | 9K |
| 2026-02-11 | Boned Frederic | SVP/GM, Human Nutri. & Health | Grant | 2K | $0.00 | $0 | 10K |
| 2026-02-11 | Boned Frederic | SVP/GM, Human Nutri. & Health | Grant | 3K | $0.00 | $0 | 8K |
| 2026-02-11 | Tignor Michael Brent | SVP & Chief HR Officer | Tax withholding | 991 | $178.68 | $177K | 11K |
| 2026-02-11 | Tignor Michael Brent | SVP & Chief HR Officer | Grant | 2K | $0.00 | $0 | 12K |
| 2026-02-11 | Tignor Michael Brent | SVP & Chief HR Officer | Grant | 1K | $0.00 | $0 | 10K |
| 2026-02-11 | Miyata Hatsuki | EVP, CLO, & Secretary | Tax withholding | 877 | $178.68 | $157K | 9K |
| 2026-02-11 | Miyata Hatsuki | EVP, CLO, & Secretary | Grant | 2K | $0.00 | $0 | 10K |
| 2026-02-11 | Miyata Hatsuki | EVP, CLO, & Secretary | Grant | 2K | $0.00 | $0 | 8K |
| 2026-02-11 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Tax withholding | 2K | $178.68 | $432K | 28K |
| 2026-02-11 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Grant | 5K | $0.00 | $0 | 31K |
| 2026-02-11 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Grant | 4K | $0.00 | $0 | 26K |
| 2026-02-11 | Wineinger Matthew David | Director | Grant | 870 | $0.00 | $0 | 8K |
| 2026-02-11 | VICENTE MONICA | Director | Grant | 870 | $0.00 | $0 | 2K |
| 2026-02-11 | Rigaud Olivier | Director | Grant | 870 | $0.00 | $0 | 2K |
| 2026-02-11 | Knutson Daniel E | Director | Grant | 870 | $0.00 | $0 | 7K |
| 2026-02-11 | Fish Kathleen B | Director | Grant | 870 | $0.00 | $0 | 3K |
| 2026-02-11 | Fischer David B | Director | Grant | 870 | $0.00 | $0 | 9K |
| 2026-02-08 | Backus William A. | VP & Chief Accounting Officer | Tax withholding | 322 | $173.16 | $56K | 6K |
| 2026-02-08 | Miyata Hatsuki | EVP, CLO, & Secretary | Tax withholding | 343 | $173.16 | $59K | 6K |
| 2026-02-08 | Harris Theodore L | Chairman, President & CEO | Tax withholding | 3K | $173.16 | $558K | 76K |
| 2026-02-08 | Boned Frederic | SVP/GM, Human Nutri. & Health | Tax withholding | 430 | $173.16 | $74K | 5K |
| 2026-02-08 | Reid Martin Luther | SVP Chief Supply Chain Officer | Tax withholding | 416 | $173.16 | $72K | 7K |
| 2026-02-08 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Tax withholding | 258 | $173.16 | $45K | 9K |
| 2026-02-08 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Tax withholding | 863 | $173.16 | $149K | 22K |
| 2026-02-08 | Tignor Michael Brent | SVP & Chief HR Officer | Tax withholding | 373 | $173.16 | $65K | 9K |
| 2025-12-04 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Sell | 2K | $153.80 | $271K | 9K |
| 2025-12-04 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Sell | 4K | $153.07 | $648K | 11K |
| 2025-12-04 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Exercise or conversion | 6K | $60.85 | $365K | 15K |
| 2025-12-03 | Fischer David B | Director | Sell | 2K | $154.15 | $308K | 8K |
| 2025-12-03 | Fischer David B | Director | Sell | 6K | $153.91 | $923K | 10K |
| 2025-12-03 | Fischer David B | Director | Exercise or conversion | 3K | $84.09 | $220K | 16K |
| 2025-12-03 | Fischer David B | Director | Exercise or conversion | 3K | $74.57 | $252K | 13K |
| 2025-11-11 | Reid Martin Luther | SVP Chief Supply Chain Officer | Sell | 1K | $154.44 | $185K | 7K |
| 2025-10-31 | Boned Frederic | SVP/GM, Human Nutri. & Health | Tax withholding | 1K | $153.39 | $166K | 6K |
| 2025-10-20 | Graham George | SVP and Chief R&D Officer | Grant | 3K | $0.00 | $0 | 3K |
| 2025-07-25 | Miyata Hatsuki | EVP, CLO, & Secretary | Tax withholding | 483 | $148.82 | $72K | 6K |
| 2025-04-01 | Backus William A. | VP & Chief Accounting Officer | Tax withholding | 383 | $167.24 | $64K | 6K |
| 2025-02-13 | Backus William A. | VP & Chief Accounting Officer | Tax withholding | 1K | $163.14 | $175K | 6K |
| 2025-02-13 | Backus William A. | VP & Chief Accounting Officer | Grant | 2K | $0.00 | $0 | 7K |
| 2025-02-13 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Grant | 5K | $0.00 | $0 | 26K |
| 2025-02-13 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Tax withholding | 3K | $163.14 | $454K | 23K |
| 2025-02-13 | Sestrick Michael Robert | SVP & Chief Technology Officer | Tax withholding | 1K | $163.14 | $170K | 5K |
| 2025-02-13 | Sestrick Michael Robert | SVP & Chief Technology Officer | Grant | 2K | $0.00 | $0 | 6K |
| 2025-02-13 | Harris Theodore L | Chairman, President & CEO | Grant | 22K | $0.00 | $0 | 91K |
| 2025-02-13 | Harris Theodore L | Chairman, President & CEO | Tax withholding | 11K | $163.14 | $1.9M | 79K |
| 2025-02-13 | Tignor Michael Brent | SVP & Chief HR Officer | Grant | 2K | $0.00 | $0 | 10K |
| 2025-02-13 | Tignor Michael Brent | SVP & Chief HR Officer | Tax withholding | 1K | $163.14 | $189K | 9K |
| 2025-02-13 | Reid Martin Luther | SVP Chief Supply Chain Officer | Grant | 3K | $0.00 | $0 | 10K |
| 2025-02-13 | Reid Martin Luther | SVP Chief Supply Chain Officer | Tax withholding | 1K | $163.14 | $173K | 9K |
| 2025-02-13 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Grant | 2K | $0.00 | $0 | 10K |
| 2025-02-13 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Tax withholding | 964 | $163.14 | $157K | 9K |
| 2025-02-12 | Rigaud Olivier | Director | Grant | 980 | $0.00 | $0 | 2K |
| 2025-02-12 | Knutson Daniel E | Director | Grant | 980 | $0.00 | $0 | 6K |
| 2025-02-12 | Fish Kathleen B | Director | Grant | 980 | $0.00 | $0 | 3K |
| 2025-02-12 | Fischer David B | Director | Grant | 980 | $0.00 | $0 | 10K |
| 2025-02-12 | Wineinger Matthew David | Director | Grant | 980 | $0.00 | $0 | 7K |
| 2025-02-12 | VICENTE MONICA | Director | Grant | 980 | $0.00 | $0 | 2K |
| 2025-02-12 | Backus William A. | VP & Chief Accounting Officer | Grant | 550 | $0.00 | $0 | 5K |
| 2025-02-12 | Boned Frederic | SVP/GM, Human Nutri. & Health | Grant | 2K | $0.00 | $0 | 7K |
| 2025-02-12 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Grant | 2K | $0.00 | $0 | 21K |
| 2025-02-12 | Miyata Hatsuki | EVP, Gen. Counsel & Secretary | Grant | 2K | $0.00 | $0 | 7K |
| 2025-02-12 | Harris Theodore L | Chairman, President & CEO | Grant | 7K | $0.00 | $0 | 68K |
| 2025-02-12 | Tignor Michael Brent | SVP & Chief HR Officer | Grant | 1K | $0.00 | $0 | 8K |
| 2025-02-12 | Reid Martin Luther | SVP Chief Supply Chain Officer | Grant | 1K | $0.00 | $0 | 7K |
| 2025-02-12 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Grant | 410 | $0.00 | $0 | 9K |
| 2025-02-10 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Tax withholding | 258 | $159.39 | $41K | 8K |
| 2025-02-10 | Tignor Michael Brent | SVP & Chief HR Officer | Tax withholding | 334 | $159.39 | $53K | 7K |
| 2025-02-10 | Sestrick Michael Robert | SVP & Chief Technology Officer | Tax withholding | 305 | $159.39 | $49K | 4K |
| 2025-02-10 | Reid Martin Luther | SVP Chief Supply Chain Officer | Tax withholding | 319 | $159.39 | $51K | 6K |
| 2025-02-10 | Harris Theodore L | Chairman, President & CEO | Tax withholding | 3K | $159.39 | $489K | 62K |
| 2025-02-10 | Bengtsson Carl Martin | EVP & Chief Financial Officer | Tax withholding | 777 | $159.39 | $124K | 18K |
| 2025-02-10 | Backus William A. | VP & Chief Accounting Officer | Tax withholding | 310 | $159.39 | $49K | 5K |
| 2024-07-31 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Sell | 8K | $180.05 | $1.4M | 9K |
| 2024-07-31 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Exercise or conversion | 4K | $60.85 | $228K | 16K |
| 2024-07-31 | van Gunsteren Job Leonard | SVP and GM, Specialty Products | Exercise or conversion | 4K | $58.52 | $234K | 13K |
| 2024-07-30 | Backus William A. | VP & Chief Accounting Officer | Sell | 904 | $177.10 | $160K | 132 |
| 2024-07-30 | Backus William A. | VP & Chief Accounting Officer | Exercise or conversion | 4K | $84.09 | $328K | 9K |
| 2024-07-30 | Backus William A. | VP & Chief Accounting Officer | Sell | 4K | $179.25 | $640K | 5K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON5 Form 144 notices on file for BCPC worth $2.6M at the prices reported; 0 in the last 90 days worth $0. Latest: Fischer David B filed on 2025-12-08 to sell 2,000 shares ($308K) from 2025-12-03.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2025-12-08 | Fischer David BDirector | 2K | $308K | 0.006% | 2025-12-03 | Stifel Nicolaus & Company Inc |
| 2025-12-04 | van Gunsteren Job LeonardOfficer | 6K | $920K | 0.019% | 2025-12-04 | Charles Schwab & Co., Inc. |
| 2025-12-03 | Fischer David BDirector | 2K | $308K | 0.006% | 2025-12-03 | Stifel Nicolaus & Company Inc |
| 2025-12-03 | Fischer David BDirector | 6K | $923K | 0.019% | 2025-12-03 | Charles Schwab & Co., Inc. |
| 2025-11-12 | Reid Martin LutherOfficer | 1K | $185K | 0.004% | 2025-11-11 | Charles Schwab & Co., Inc. |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of BCPC in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Portfolio Management at 6.9% of the class (2,221,969 shares), filed 2026-04-28 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 1.7M | 5.2% | 2026-03-31 |
| 2026-04-28 | 13G | Vanguard Portfolio Managementinvestment adviser | 2.2M | 6.9% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 14 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding BCPC at their latest 13F. JSON8 of the 30 tracked managers held BCPC at their latest 13F, $179.8M in total at quarter-end prices. Two Sigma Investments is the largest at $84.8M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 502K | $84.8M | 0.06% | +72K |
| Renaissance Technologies | 2026-06-30 | 193K | $32.7M | 0.04% | +16K |
| Millennium Management | 2026-06-30 | 185K | $31.2M | 0.01% | +67K |
| AQR Capital Management | 2026-06-30 | 74K | $12.6M | 0.00% | -6K |
| Citadel Advisors | 2026-06-30 | 62K | $10.4M | 0.00% | +41K |
| Point72 Asset Management | 2026-06-30 | 26K | $4.4M | 0.00% | -67K |
| Bridgewater Associates | 2026-06-30 | 13K | $2.3M | 0.01% | -4K |
| D. E. Shaw & Co. | 2026-06-30 | 9K | $1.5M | 0.00% | -31K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Balchem reported revenue of $284.0M, up 11.2% from the same quarter a year earlier, and net income of $44.6M (1.39 diluted EPS). In FY 2025 it generated $216.6M of operating cash flow and spent $107.6M on buybacks and $28.3M on dividends.
- Cash
- $63.2M
- Equity
- $1.30B
- Total assets
- $1.69B
- Shares outstanding
- 31,878,021
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $284.0M | $44.6M | 15.7% | 1.39 |
| Q1 FY 2026 | 2026-03-31 | $270.7M | $40.3M | 14.9% | 1.25 |
| Q4 FY 2025 | 2025-12-31 | $263.6M | $39.2M | 14.9% | 1.21 |
| Q3 FY 2025 | 2025-09-30 | $267.6M | $40.3M | 15.1% | 1.24 |
| Q2 FY 2025 | 2025-06-30 | $255.5M | $38.3M | 15.0% | 1.17 |
| Q1 FY 2025 | 2025-03-31 | $250.5M | $37.1M | 14.8% | 1.13 |
| Q4 FY 2024 | 2024-12-31 | $240.0M | $33.6M | 14.0% | 1.03 |
| Q3 FY 2024 | 2024-09-30 | $239.9M | $33.8M | 14.1% | 1.03 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.04B | $154.8M | $216.6M | n/a | $107.6M | $28.3M |
| FY 2024 | 2024-12-31 | $953.7M | $128.5M | $182.0M | n/a | $5.7M | $25.6M |
| FY 2023 | 2023-12-31 | $922.4M | $108.5M | $183.8M | n/a | $4.5M | $22.9M |
| FY 2022 | 2022-12-31 | $942.4M | $105.4M | $138.5M | $49.1M | $35.4M | $20.7M |
| FY 2021 | 2021-12-31 | $799.0M | $96.1M | $160.5M | $36.1M | $35.2M | $18.7M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-23 from the cover page.
What this page is
Balchem in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Balchem (BCPC), SEC CIK 9326, listed on Nasdaq, classified by the SEC as chemicals & allied products. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2025-12-08.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-23.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-02-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 9326Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as chemicals & allied products
Other company pages
Datasets
Frequently Asked Questions
How much of BCPC is sold short?
493,011 shares were held short at the 2026-09-30 settlement, 2.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is BCPC's daily short volume?
On 2026-10-23, 73,972 of the 124,148 BCPC shares reported to FINRA were sold short, 59.6% of the day's reported volume. Short volume is a flow for one day, not a position.
Does BCPC have fails to deliver?
The SEC's latest file shows 29 BCPC shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are BCPC insiders buying or selling?
No open-market insider trades were reported for BCPC in the last 90 days. The most recent filings are listed below. Latest filing: van Gunsteren Job Leonard (SVP and GM, Specialty Products) on 2026-02-12.
Have BCPC insiders filed to sell?
5 Form 144 notices on file for BCPC worth $2.6M at the prices reported; 0 in the last 90 days worth $0. Latest: Fischer David B filed on 2025-12-08 to sell 2,000 shares ($308K) from 2025-12-03.
Who owns 5% or more of BCPC?
2 holders report 5% or more of BCPC in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Portfolio Management at 6.9% of the class (2,221,969 shares), filed 2026-04-28 for an event on 2026-03-31.
What did BCPC report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Balchem reported revenue of $284.0M, up 11.2% from the same quarter a year earlier, and net income of $44.6M (1.39 diluted EPS). In FY 2025 it generated $216.6M of operating cash flow and spent $107.6M on buybacks and $28.3M on dividends.
Which tracked 13F managers own BCPC?
8 of the 30 tracked 13F managers held BCPC shares at their latest filing, $179.8M in all. The largest: Two Sigma Investments (502K shares, $84.8M), Renaissance Technologies (193K shares, $32.7M), Izzy Englander's Millennium Management (185K shares, $31.2M), Cliff Asness's AQR Capital Management (74K shares, $12.6M), Ken Griffin's Citadel Advisors (62K shares, $10.4M), Steve Cohen's Point72 Asset Management (26K shares, $4.4M). The table above lists all 8.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.